The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dierks Jeffrey since 2021.
This trader's CIK number is 1821102.
At the time of last reporting, Dierks Jeffrey was the CHIEF COMMERCIAL OFFICER of Harmony Biosciences Holdings, Inc.. (stock ticker symbol HRMY).
Also see all insider trading activities at Harmony Biosciences Holdings, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | HRMY | 0 | $0 | 67,908 | $2,515,725 | 68,966 | $1,897,307 |
| 2024 | HRMY | 0 | $0 | 70,432 | $2,562,007 | 94,075 | $628,771 |
| 2022 | HRMY | 0 | $0 | 72,995 | $3,272,476 | 68,936 | $1,480,978 |
| 2021 | HRMY | 0 | $0 | 45,000 | $1,587,145 | 45,000 | $369,900 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-03 | HRMY | Option Ex | 4,869 | 8.22 | 40,023 |
| 2025-03-03 | HRMY | Sale | 4,869 | 32.92 | 160,287 |
| 2025-01-24 | HRMY | Option Ex | 15,812 | 15.35 | 242,635 |
| 2025-01-24 | HRMY | Sale | 13,125 | 37.41 | 490,980 |
| 2025-01-27 | HRMY | Sale | 1,629 | 38.02 | 61,941 |
| 2025-01-16 | HRMY | Sale | 29,475 | 37.41 | 1,102,807 |
| 2025-01-16 | HRMY | Option Ex | 29,475 | 33.44 | 985,643 |
| 2025-01-21 | HRMY | Sale | 1,123 | 40.00 | 44,920 |
| 2025-01-21 | HRMY | Option Ex | 1,123 | 33.44 | 37,553 |
| 2025-01-15 | HRMY | Option Ex | 10,507 | 33.44 | 351,354 |
| 2025-01-15 | HRMY | Sale | 10,507 | 37.01 | 388,843 |
| 2025-01-13 | HRMY | Sale | 7,180 | 37.04 | 265,947 |
| 2025-01-13 | HRMY | Option Ex | 7,180 | 33.44 | 240,099 |
| 2024-10-29 | HRMY | Option Ex | 21,496 | 24.00 | 515,904 |
| 2024-10-29 | HRMY | Sale | 21,496 | 40.47 | 870,029 |
| 2024-10-03 | HRMY | Sale | 36,357 | 35.33 | 1,284,565 |
| 2024-10-01 | HRMY | Option Ex | 400 | 24.00 | 9,600 |
| 2024-10-01 | HRMY | Sale | 400 | 40.19 | 16,076 |
| 2024-09-30 | HRMY | Option Ex | 60,000 | .00 | 0 |
| 2024-09-27 | HRMY | Option Ex | 200 | 24.00 | 4,800 |
| 2024-09-27 | HRMY | Sale | 200 | 40.05 | 8,009 |
| 2024-03-15 | HRMY | Option Ex | 11,979 | 8.22 | 98,467 |
| 2024-03-15 | HRMY | Sale | 11,979 | 32.00 | 383,328 |
| 2022-08-22 | HRMY | Sale | 28,971 | 47.26 | 1,369,140 |
| 2022-08-22 | HRMY | Option Ex | 28,971 | 24.00 | 695,304 |
| 2022-04-01 | HRMY | Option Ex | 14,471 | 24.00 | 347,304 |
| 2022-04-01 | HRMY | Sale | 14,471 | 49.61 | 717,935 |
| 2022-03-01 | HRMY | Sale | 4,869 | 40.04 | 194,959 |
| 2022-02-28 | HRMY | Sale | 10,041 | 40.00 | 401,650 |
| 2022-03-01 | HRMY | Option Ex | 4,869 | 8.22 | 40,023 |
| 2022-02-28 | HRMY | Option Ex | 10,041 | 24.00 | 240,984 |
| 2022-02-17 | HRMY | Sale | 4,259 | 40.02 | 170,423 |
| 2022-02-16 | HRMY | Option Ex | 4,259 | 24.00 | 102,216 |
| 2022-02-17 | HRMY | Option Ex | 200 | 24.00 | 4,800 |
| 2022-02-16 | HRMY | Sale | 4,259 | 40.05 | 170,589 |
| 2022-01-06 | HRMY | Sale | 6,125 | 40.45 | 247,780 |
| 2022-01-06 | HRMY | Option Ex | 6,125 | 8.22 | 50,347 |
| 2021-11-01 | HRMY | Sale | 10,000 | 41.90 | 418,960 |
| 2021-11-01 | HRMY | Option Ex | 10,000 | 8.22 | 82,200 |
| 2021-09-07 | HRMY | Option Ex | 5,000 | 8.22 | 41,100 |
| 2021-09-07 | HRMY | Sale | 5,000 | 37.00 | 185,000 |
| 2021-09-01 | HRMY | Sale | 10,000 | 33.78 | 337,760 |
| 2021-09-01 | HRMY | Option Ex | 10,000 | 8.22 | 82,200 |
| 2021-08-26 | HRMY | Option Ex | 1,600 | 8.22 | 13,152 |
| 2021-08-27 | HRMY | Option Ex | 3,400 | 8.22 | 27,948 |
| 2021-08-26 | HRMY | Sale | 1,600 | 35.01 | 56,020 |
| 2021-08-27 | HRMY | Sale | 3,400 | 35.18 | 119,605 |
| 2021-06-15 | HRMY | Sale | 15,000 | 31.32 | 469,800 |
| 2021-06-15 | HRMY | Option Ex | 15,000 | 8.22 | 123,300 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dierks Jeffrey (CHIEF COMMERCIAL OFFICER of Harmony Biosciences Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.